Government Safety Review Urges Women to Discuss Epilepsy Treatment Options Before Pregnancy

15th February 2021

A new government review has found that four of the top most popular epilepsy medications can result in physical defects or learning difficulties for children when taken during pregnancy.  The Medicines and Healthcare Products Regulatory Agency (MHRA) analysed the 10 most common epilepsy medications and found that 4 of them could pose a potential risk…

Read more

Category: News

Self-limited Neonatal Convulsions

8th February 2021

A relatively uncommon syndrome, self-limited neonatal convulsions occurs in babies and young infants and initially presents with seizures which start in the first 28 days of life (the neonatal period). This syndrome was once informally known as ‘5th day fits’ as it often starts on the 5th day of life, although in reality can be…

Read more

Category: Syndromes

Bedrocan Supply Threat – An Open Letter from National Epilepsy Training

1st February 2021

We recently wrote a post on how the threat of a halt of prescriptions for cannabis-based medication, Bedrocan, is going to affect 42 families within the UK.  One of the 42 children affected is one of our own clients here at National Epilepsy Training.  Our client is only 12 years old, and can have up…

Read more

Category: News

Parents Fear as Brexit Cuts Off Supply of ‘Life Saving’ Cannabis-based Medication

31st January 2021

Supplies of medical cannabis have been halted due to Brexit, which has left around 40 parents fearing for their child’s safety as they were reliant on the medication.  One case is that of Alfie Dingley, a 9 year old boy, who used to experience up to 150 seizures a day, which led to his mother…

Read more

Category: News